You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail - Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

Continuous support by Kedrion Biopharma to research and partnering patient associations

read more 
For more information please contact: pressoffice@kedrion.com